Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482. doi: 10.1002/14651858.CD007482.pub2
Methods RCT; 3 parallel groups.
Unit of randomization: individual.

Participants Dates of data collection: November 1981-March 1982.
Setting: University of Parma, Parma, Italy.
Inclusion criteria: women undergoing emergency CS (58/60 women in spontaneous labor; classified as non-elective)
Exclusion criteria: allergy to penicillin or cephalosporins; severe renal disease, history of pelvic infections

Interventions Cefuroxime 750 mg IM 30-60 minutes before surgery and 8 and 16 hours after (short term)(N = 20) vs 750 mg 3 times a day for 5 days (first dose being given post-operatively after the woman had returned to the ward) (long term) (N = 20) vs no treatment (N = 20). The results of both treatment groups have been combined

Outcomes Fever (> 100.3°F twice 6 hr apart); endometritis (fever and uterine tenderness); maternal stay (treatment 7.1 vs control 7.9 days, no variance given)

Notes Note: the group given long-term prophylaxis received the first dose after return to the ward
Class of antibiotic: second generation cephalosporin.
Subgroups:
  • non-elective CS;

  • timing of administration not specified.


Risk of bias

Item Authors’ judgement Description

Adequate sequence generation? Unclear Randomly assigned.
No further information.

Allocation concealment? Unclear No information was provided.

Blinding? Unclear Not placebo controlled.
All outcomes

Incomplete outcome data addressed? Unclear No losses to follow up reported.
All outcomes 1 woman was excluded because of an allergic reaction to cefuroxime
Could not be re-included in ITT analysis.

Free of selective reporting? Unclear Insufficient information to judge.

Free of other bias? Unclear The 3 groups were comparable.There was insufficient other information which to judge

Overall low risk of bias? Unclear All sections unclear.
HHS Vulnerability Disclosure